News Channels

20 Dec 2019 Agenus Commences Combination Trial of its Next-Gen CTLA-4 with its PD-1 Antibody
20 Dec 2019 InxMed Receives Approval to Initiate Phase I Clinical Trial in China for IN10018
20 Dec 2019 VistaGen and Baylor College of Medicine Announce Successful Results of First-Step Target Engagement Study with VistaGen's AV-101 Focused on Treating Suicidal Ideation in Veterans
20 Dec 2019 AlzeCure Initiates Clinical Trial With ACD856
20 Dec 2019 REGENXBIO Announces Interim Data from Phase I/II Trial of RGX-121 for the Treatment of Mucopolysaccharidosis Type II (MPS II)
20 Dec 2019 GSK announces positive headline results in phase 3 study of Benlysta in patients with lupus nephritis
20 Dec 2019 AbbVie Receives European Commission Approval of RINVOQ™ (upadacitinib) for the Treatment of Adults with Moderate to Severe Active Rheumatoid Arthritis
20 Dec 2019 PharmaMar and Jazz Pharmaceuticals Sign Exclusive License Agreement for Lurbinectedin in the U.S.
20 Dec 2019 Amgen And Allergan Submit Biologics License Application For ABP 798, Biosimilar Candidate To Rituxan® (rituximab), To U.S. Food And Drug Administration
20 Dec 2019 First FDA-approved vaccine for the prevention of Ebola virus disease, marking a critical milestone in public health preparedness and response
20 Dec 2019 Bridge Biotherapeutics Files Investigational New Drug Application for BBT-176, an EGFR TKI for NSCLC
20 Dec 2019 Follica Announces Positive Topline Data from Clinical Study in Male Androgenetic Alopecia
20 Dec 2019 Gilead Submits Filgotinib New Drug Application to U.S. Food and Drug Administration Under Priority Review for Rheumatoid Arthritis Treatment
20 Dec 2019 Poxel and Sumitomo Dainippon Pharma Announce Positive Topline Phase 3 Results from TIMES 2 Trial of Imeglimin for the Treatment of Type 2 Diabetes in Japan and Successful Completion of the Pivotal TIMES Clinical Development Program
20 Dec 2019 Galderma receives a positive outcome through the European Decentralised Procedure for AKLIEF® (trifarotene 50 mcg/g cream), the first new retinoid molecule for acne in the European Union in 25 years1
20 Dec 2019 MODAG Initiates First-in-Human Phase 1 Clinical Trial for Anle138b
20 Dec 2019 Zentalis Pharmaceuticals Announces FDA Clearance of the IND for Its Third Oncology Drug Candidate, ZN-c3, a WEE1 Inhibitor, and the Dosing of the First Patient in a Phase 1/2 Clinical Trial
20 Dec 2019 Seattle Genetics Announces U.S. FDA Grants Breakthrough Therapy Designation for Tucatinib in Locally Advanced or Metastatic HER2-Positive Breast Cancer
20 Dec 2019 NeuClone Completes Dosing in Phase I Clinical Trial of Stelara® (ustekinumab) Biosimilar Candidate
20 Dec 2019 Eleusis Announces Phase 1 Trial Results of Lysergic Acid Diethylamide (LSD) in Healthy Older Volunteers, Potential to Evaluate as Disease Modifying Therapy for Alzheimer’s Disease

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up